Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
NCT02578121Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by University of Arkansas. Planned start Dec 2015; status: withdrawn.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02578121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578121.